These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 26903722)
1. Experience of intravitreal injections in a tertiary Hospital in Oman. Al-Hinai AS Oman J Ophthalmol; 2015; 8(3):166-70. PubMed ID: 26903722 [TBL] [Abstract][Full Text] [Related]
3. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
4. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Wu L; Martínez-Castellanos MA; Quiroz-Mercado H; Arevalo JF; Berrocal MH; Farah ME; Maia M; Roca JA; Rodriguez FJ; Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):81-7. PubMed ID: 17674014 [TBL] [Abstract][Full Text] [Related]
5. Safety and complications of intravitreal injections performed in an Asian population in Singapore. Xu Y; Tan CS Int Ophthalmol; 2017 Apr; 37(2):325-332. PubMed ID: 27236451 [TBL] [Abstract][Full Text] [Related]
6. Bilateral simultaneous intravitreal injections in the office setting. Bakri SJ; Risco M; Edwards AO; Pulido JS Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
8. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [TBL] [Abstract][Full Text] [Related]
13. Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study). Ehrlich R; Pokroy R; Segal O; Goldstein M; Pollack A; Hanhart J; Barak Y; Kehat R; Shulman S; Vidne O; Abu Ahmad W; Chowers I Eur J Ophthalmol; 2019 Mar; 29(2):229-233. PubMed ID: 29916263 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM Retina; 2005; 25(7):846-50. PubMed ID: 16205562 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide: a change in a paradigm. Jonas JB Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379 [TBL] [Abstract][Full Text] [Related]
16. Same-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center. Juncal VR; Francisconi CLM; Altomare F; Chow DR; Giavedoni LR; Muni RH; Berger AR; Wong DT Ophthalmologica; 2019; 242(1):1-7. PubMed ID: 30928983 [TBL] [Abstract][Full Text] [Related]
17. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Wong LJ; Desai RU; Jain A; Feliciano D; Moshfeghi DM; Sanislo SR; Blumenkranz MS Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542 [TBL] [Abstract][Full Text] [Related]
18. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema. Mukkamala L; Bhagat N; Zarbin MA Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069 [TBL] [Abstract][Full Text] [Related]
19. Complications of intravitreal steroid injections. Reichle ML Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow. Cekiç O; Bardak Y; Tiğ SU; Demirkol A; Ekim MM; Altintaş O; Yeşildağ A; Oyar O Int Ophthalmol; 2007 Oct; 27(5):313-9. PubMed ID: 17505781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]